Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
- Oil prices settle at pre-Iran war levels as crude output grows
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
Bio-Techne Corp. (TECH) PT Raised to $560 at Stifel
August 5, 2021 3:56 PM EDTStifel analyst Daniel Arias raised the price target on Bio-Techne Corp. (NASDAQ: TECH) to $560.00 (from $475.00) while maintaining a Buy rating.
The analyst commented, "Bio-Techne posted another strong quarter on the heels of the lab spending rebound and demand for a portfolio that... More
Bio-Techne (TECH) Tops Q4 EPS by 17c
August 5, 2021 6:52 AM EDTBio-Techne (NASDAQ: TECH) reported Q4 EPS of $1.87, $0.17 better than the analyst estimate of $1.70. Revenue for the quarter came in at $259 million versus the consensus estimate of $244.62 million.
For earnings history and earnings-related data on Bio-Techne (TECH) click here.
... More